Additionally, a tumor-associated inflammatory mediator, prostaglandin E2 (PGE2), has demonstrated a role in controlling the expression and interactions of CXCL12 and its respective receptor, CXCR4, which are implicated in the process of tumor progression (42). The gene discussed is CXCL12; the disease is neoplasm.